Ultragenyx Pharmaceutical | RARE - Trade Creditors

Stock Price
25.00
Daily Change
-0.80 -3.10%
Monthly
1.96%
Yearly
-29.80%
Q2 Forecast
24.50

Ultragenyx Pharmaceutical reported $42M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 12.25M 1.34M Mar/2026
Agios Pharmaceuticals USD 13.75M 4.61M Mar/2026
Alnylam Pharmaceuticals USD 126.63M 10.91M Mar/2026
BioCryst Pharmaceuticals USD 10.96M 4.87M Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Esperion Therapeutics USD 68.41M 3.34M Mar/2026
Immunic USD 11.01M 873K Mar/2026
Insmed USD 73.38M 6.53M Mar/2026
Ionis Pharmaceuticals USD 26.03M 2.05M Mar/2026
Karyopharm Therapeutics USD 4M 1.39M Dec/2025
Kyowa Hakko Kirin JPY 107.59B 17.46B Mar/2026
MacroGenics USD 4.29M 500K Mar/2026
Moderna USD 161M 156M Mar/2026
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
PTC Therapeutics USD 25.48M 20M Mar/2026
Puma Biotechnology USD 6.39M 962K Sep/2025
Regeneron Pharmaceuticals USD 1.03B 4.81B Mar/2026
Sarepta Therapeutics USD 70.38M 210.46M Mar/2026
Ultragenyx Pharmaceutical USD 42M 11M Mar/2026
Vertex Pharmaceuticals USD 3.47B 40.6M Mar/2026
Xoma USD 2.65M 1.52M Sep/2025